Travelers Diarrhea

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2015-06-10
Clinical Trial Update: Single Daily Dose Rifaximin for the Treatment of Travelers' Diarrhea [Phase 4]
A Phase 4 clinical trial evaluating a single daily dose of rifaximin for travelers' diarrhea has been withdrawn.